TSH Biopharm Corporation

In 2023, TSH Biopharm Corporation reported total carbon emissions of approximately 56,081.5 kg CO2e, with emissions distributed across various scopes. Specifically, Scope 1 emissions were about 0.9 kg CO2e, while Scope 2 emissions accounted for approximately 56,080.6 kg CO2e. The company’s Scope 3 emissions were significant, totalling around 42,861.2 kg CO2e from upstream transportation and distribution, alongside other categories such as employee commute and purchased goods and services. Comparatively, in 2022, TSH Biopharm's total emissions were approximately 57,000 kg CO2e, with Scope 1 emissions remaining constant at about 120 kg CO2e and Scope 2 emissions increasing to approximately 18,000 kg CO2e. In 2021, the total emissions were about 734,120 kg CO2e, with Scope 1 at 120 kg CO2e and Scope 2 at 13,700 kg CO2e, indicating a trend of increasing emissions in the earlier years. Despite these figures, TSH Biopharm has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. The company operates within a global context where many organisations are increasingly focusing on sustainability and carbon neutrality, yet TSH Biopharm's current commitments remain unspecified.